258 Generali Group Annual Integrated Report and Consolidated Financial Statements 2018
Additional information
43 Disclosure regarding the 
– subordinated liabilities that qualify as own funds pur-
deferred application of IFRS 9  suant to the Solvency II regulations (€ 9 billion);
– liabilities arising from defined benefit plans of Group 
“Financial Instruments”
companies operating in the Life and P&C segments  
(€ 4 billion);
The Group adopted the temporary exemption from the  – tax liabilities related to insurance operations (€ 4 billion).
application of IFRS 9, as provided for in the amendment to 
IFRS 4 “Applying IFRS 9 Financial Instruments with IFRS  The other liabilities, not related to insurance operations, 
4 Insurance Contracts”. The Group qualifies for temporary  consist mainly of liabilities to banks and bank customers.
exemption from application of IFRS 9. In fact, the carrying 
amount of liabilities for insurance operations (€ 443 billion)  The information required by the amendment to IFRS 4 for 
is higher than 90% of the carrying amount of total liabil- financial instruments as at 31 December 2018 is provid-
ities (€ 476 billion) as of 31 December 2015 (application  ed below.
period required by the principle. Specifically, the liabilities 
related to insurance operations not included in the scope  Change in the fair value of financial instruments included 
of IFRS 4 are listed below: in the scope of application of IFRS 9 with the details of 
– non-derivative liabilities linked to investment contracts  financial instruments that give rise to specific dates for 
measured at fair value through profit and loss, for  cash flows that consist exclusively of payment of princi-
which IAS 39 applies (€ 22 billion); pal and interest. 
Change in fair value of financial instruments in scope of IFRS 9
31/12/2018 31/12/2018 Change in the fair value since 
31 December 2017
Financial assets managed on fair value basis and held for trading* 77,459 -
Equities 87 -
Investment funds 8,457 -
Derivatives 1,261 -
Investments back to policies where the risk is borne by the policyholders and pension 
63,749 -
funds**
Other financial instruments managed on fair value basis 3,905 -
Available for sale financial assets (AFS), held to maturity and loans and receivables*** 339,848 -11,134
Financial assets that give rise on specified dates to cash flows that are solely payments of 
297,588 -8,199
principal and interest
Bonds 277,472 -8,283
Loans and other debt instruments 18,400 84
Receivables from banks and customers 1,648 0
Other investments 69 0
Financial assets that do not give rise on specified dates to cash flows that are solely 
42,260 -2,935
payments of principal and interest****
Equities 10,379 -1,722
Investment funds 22,830 -921
Bonds 8,705 -284
Loans and other debt instruments 295 -8
Receivables from banks and customers 49 0
Other financial instruments that do not give rise on specified dates to cash flows that 
1 0
are solely payments of principal and interest
*,** The fair value change of financial assets measured at fair value through profit or loss is provided in the relative section in the notes.
*** Policy loans and leashold assets are excluded from the scope of SPPI test because in the scope respectively of insurance contracts and leases
**** These assets would be measured as at fair value through profit or loss if IFRS 9 was applied.